RNTX

Rein Therapeutics

16 hedge funds and large institutions have $1.59M invested in Rein Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

13% less capital invested

Capital invested by funds: $1.83M → $1.59M (-$241K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$30.4K
2 +$4.74K
3 +$2.21K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.17K

Top Sellers

1 -$2.43K
2 -$1.02K
3 -$819
4
IGWM
ICA Group Wealth Management
Colorado
-$179
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.26M
2
$85.3K
3
$60.7K
4
$44.1K
5
$34K
6
$30.4K
7
$29K
8
$29K
9
$6.85K
10
$2.42K
11
$1.9K
12
$1.9K
13
$287
14
$190
15
$36
16
17